Corbus Pharmaceuticals Holdings, Inc. Quarterly Nonoperating Income (Expense) in USD from Q3 2013 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).
Summary
Corbus Pharmaceuticals Holdings, Inc. quarterly/annual Nonoperating Income (Expense) history and growth rate from Q3 2013 to Q3 2024.
  • Corbus Pharmaceuticals Holdings, Inc. Nonoperating Income (Expense) for the quarter ending September 30, 2024 was $1.72M.
  • Corbus Pharmaceuticals Holdings, Inc. Nonoperating Income (Expense) for the twelve months ending September 30, 2024 was $7.52M.
  • Corbus Pharmaceuticals Holdings, Inc. annual Nonoperating Income (Expense) for 2023 was $474K.
  • Corbus Pharmaceuticals Holdings, Inc. annual Nonoperating Income (Expense) for 2022 was -$2.51M, a 124% decline from 2021.
  • Corbus Pharmaceuticals Holdings, Inc. annual Nonoperating Income (Expense) for 2021 was $10.3M, a 10.3% decline from 2020.
Nonoperating Income (Expense), Trailing 12 Months (USD)
Nonoperating Income (Expense), Quarterly (USD)
Nonoperating Income (Expense), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 $7.52M $1.72M +$2.29M Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-07
Q2 2024 $5.23M $991K +$1.59M Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-06
Q1 2024 $3.65M $2.72M +$3.17M Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-07
Q4 2023 $474K $2.08M +$2.16M Oct 1, 2023 Dec 31, 2023 10-K 2024-03-12
Q3 2023 -$1.69M -$565K +$35.3K +5.88% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-07
Q2 2023 -$1.73M -$595K +$314K +34.5% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-06
Q1 2023 -$2.04M -$448K +$472K +51.3% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-07
Q4 2022 -$2.51M -$82.2K +$180K +68.7% Oct 1, 2022 Dec 31, 2022 10-K 2024-03-12
Q3 2022 -$2.69M -$600K -$12.3M -105% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-07
Q2 2022 $9.61M -$909K -$472K -108% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-08
Q1 2022 $10.1M -$920K -$269K -41.3% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-09
Q4 2021 $10.3M -$262K -$12.5M -102% Oct 1, 2021 Dec 31, 2021 10-K 2023-03-07
Q3 2021 $22.8M $11.7M +$12.6M Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-08
Q2 2021 $10.2M -$437K -$471K -1411% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-09
Q1 2021 $10.7M -$651K -$879K -385% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-10
Q4 2020 $11.5M $12.2M +$11.6M +1902% Oct 1, 2020 Dec 31, 2020 10-K 2022-03-08
Q3 2020 -$50K -$921K -$5.23M -121% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-12
Q2 2020 $5.18M $33.4K -$414K -92.5% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-12
Q1 2020 $5.59M $228K -$59.5K -20.7% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-13
Q4 2019 $5.65M $610K +$325K +114% Oct 1, 2019 Dec 31, 2019 10-K 2021-03-15
Q3 2019 $5.33M $4.31M +$4.01M +1351% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-09
Q2 2019 $1.32M $447K +$123K +37.9% Apr 1, 2019 Jun 30, 2019 10-Q/A 2020-08-31
Q1 2019 $1.19M $288K +$118K +69.8% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-11
Q4 2018 $1.08M $285K +$117K +69.3% Oct 1, 2018 Dec 31, 2018 10-K 2020-03-16
Q3 2018 $959K $297K +$306K Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-07
Q2 2018 $653K $324K +$330K Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-08
Q1 2018 $324K $170K +$182K Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-09
Q4 2017 $141K $168K +$166K +7692% Oct 1, 2017 Dec 31, 2017 10-K 2018-03-12
Q3 2017 -$24.9K -$8.81K +$4.19K +32.2% Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-08
Q2 2017 -$29.1K -$5.32K -$7.56K -338% Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-08
Q1 2017 -$21.5K -$12.9K -$7.88K -157% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-10
Q4 2016 -$13.6K $2.16K -$22 -1.01% Oct 1, 2016 Dec 31, 2016 10-K 2018-03-12
Q3 2016 -$13.6K -$13K -$14K -1353% Jul 1, 2016 Sep 30, 2016 10-K 2018-03-12
Q2 2016 $440 $2.24K +$2.08K Apr 1, 2016 Jun 30, 2016 10-K 2018-03-12
Q1 2016 -$1.64K -$5.02K -$4.6K Jan 1, 2016 Mar 31, 2016 10-K 2018-03-12
Q4 2015 $2.95K $2.18K +$3.43K Oct 1, 2015 Dec 31, 2015 10-K 2018-03-12
Q3 2015 -$476 $1.04K -$158K -99.3% Jul 1, 2015 Sep 30, 2015 10-Q 2016-11-10
Q2 2015 $157K $155* +$40.5K Apr 1, 2015 Jun 30, 2015 10-Q 2016-08-12
Q1 2015 $117K -$419* +$9.92K Jan 1, 2015 Mar 31, 2015 10-Q 2016-05-13
Q4 2014 $107K -$1.25K Oct 1, 2014 Dec 31, 2014 10-K 2016-03-28
Q3 2014 $159K +$173K Jul 1, 2014 Sep 30, 2014 10-Q 2015-11-10
Q2 2014 -$40.3K Apr 1, 2014 Jun 30, 2014 10-Q 2015-08-13
Q1 2014 -$10.3K Jan 1, 2014 Mar 31, 2014 10-Q 2015-05-13
Q3 2013 -$14.2K Jul 1, 2013 Sep 30, 2013 10-Q 2014-11-13
* An asterisk sign (*) next to the value indicates that the value is likely invalid.